Skip to main content

Advertisement

Log in

Lung metastasectomy for postoperative colorectal cancer in patients with a history of hepatic metastasis

  • Original Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objectives

Our objective was to evaluate the efficacy of pulmonary metastasectomy for postoperative colorectal cancer with hepatic metastasis, and to investigate the role of clinicopathological factors as predictors of outcome.

Methods

Consecutive patients undergoing pulmonary metastasectomy for colorectal cancer with (group PH, n = 27) or without (group P, n = 46) a history of hepatic metastasis were included in the study. Clinicopathological variables, including sex, age, site, carcinoembryonic antigen in the primary tumor, disease-free interval, prior hepatic resection, timing of pulmonary metastases, preoperative chemotherapy, type of pulmonary resection, and number, size, and location of pulmonary metastases were retrospectively collected and investigated for prognostic significance.

Results

Five-year survival rates were 59.5 and 70.0 % for patients with and without a history of hepatic metastasis, respectively; these values did not differ significantly. Among all investigated prognostic variables, sex and number of pulmonary metastases (1 vs. >1) were the most important factors affecting the outcome after colorectal and pulmonary resection. There was no significant difference in overall survival whether it was calculated from the time of resection of the primary colorectal cancer or of pulmonary metastases.

Conclusions

Pulmonary resection is not contraindicated in clinical practice. Significant factors indicating a good prognosis were female sex and the number of pulmonary metastases. Special attention should be paid to comparison of survival among studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Fusai G. Davidson BR: management of colorectal liver metastases. Colorectal Dis. 2003;5:2–23.

    Article  PubMed  CAS  Google Scholar 

  2. Miller G, Biernacki P, Kemeny NE, Gonen M, Downey R, Jarnagin WR, et al. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg. 2007;205:231–8.

    Article  PubMed  Google Scholar 

  3. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Ann Surg. 1999;230:309–21.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  4. Robert JH, Ambrogi V, Mermillod B, Dahabreh D, Goldstraw P. Factors influencing long-term survival after lung metastasectomy. Ann Thorac Surg. 1997;63:777–84.

    Article  PubMed  CAS  Google Scholar 

  5. Pihl E, Hughes ES, McDermott FT, Johnson WR, Katrivessis H. Lung recurrence after curative surgery for colorectal cancer. Dis Colon Rectum. 1987;30:417–9.

    Article  PubMed  CAS  Google Scholar 

  6. Goya T, Miyazawa N, Kondo H, Tsuchiya R, Naruke T, Suemasu K. Surgical resection of pulmonary metastases from colorectal cancer: 10-year follow-up. Cancer. 1989;64:1418–21.

    Article  PubMed  CAS  Google Scholar 

  7. Mansel JK, Zinsmeister AR, Pairolero PC, Jett JR. Pulmonary resection of metastatic colorectal adenocarcinoma. A 10 years experience. Chest. 1986;89:109–12.

    Article  PubMed  CAS  Google Scholar 

  8. Riquet M, Foucault C, Cazes A, Mitry E, Dujon A, Le Pimpec Barthes F, et al. Pulmonary resection for metastases of colorectal adenocarcinoma. Ann Thorac Surg. 2010;89:375–80.

    Article  PubMed  Google Scholar 

  9. Watanabe K, Nagai K, Kobayashi A, Sugito M, Saito N. Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer. Br J Surg. 2009;96:1058–65.

    Article  PubMed  CAS  Google Scholar 

  10. (The back-of-the-book spreadsheets). In: The Japanese Society for cancer of the colon and rectum, editor. The Guidelines for the Treatment of Colorectal Cancer. Year 2010 ed. Tokyo: Kanehara & Co., Ltd.; 2010. p. 60–1.

  11. Sclafani F, Incarbone M, Rimassa L, Personeni N, Giordano L, Alloisio M, et al. The role of hepatic emtastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer. J Thorac Cardiovasc Surg. 2013;145:97–103.

    Article  PubMed  Google Scholar 

  12. Sakamoto Y, Sakaguchi Y, Oki E, Minami K, Toh Y, Okamura T. Surgical outcomes after resection of both hepatic and pulmonary metastases from colorectal cancer. Wolrd J Surg. 2012;36:2708–13.

    Google Scholar 

  13. Thomhord NR, Wooler LB, Clagett OT. The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg. 1965;49:357–63.

    Google Scholar 

  14. Rougier P, Milan C, Lazorthes F, Fourtanier G, Partensky C, Baumel H, et al. Prospective study of prognostic factors in patients with unresected metastases from colorectal cancer. Br J Surg. 1995;82:1397–400.

    Article  PubMed  CAS  Google Scholar 

  15. Miller G, Biernacki P, Kemeny NE, Gonen M, Downey R, Jarnagin WR, et al. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J Am Coll Surg. 2007;205:231–8.

    Article  PubMed  Google Scholar 

  16. Kobayashi K, Kawamura M, Ishihara T. Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer. J Thorac Cardiovasc Surg. 1999;118:1090–6.

    Article  PubMed  CAS  Google Scholar 

  17. Nagakura S, Shirai Y, Yamato Y, Yokoyama N, Suda T, Hatakeyama K. Simultaneous detection of colorectal carcinoma liver and lung metastases does not warrant resection. J Am Coll Surg. 2001;193:153–60.

    Article  PubMed  CAS  Google Scholar 

  18. Mineo TC, Ambrogi V, Tonini G, Bollero P, Roselli M, Mineo D, et al. Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg. 2003;197:386–91.

    Article  PubMed  Google Scholar 

  19. Schüle S, Dittmar Y, Knösel T, Krieg P, Albrecht R, Settmacher U, et al. Long-term results and prognostic factors after resection of hepatic and pulmonary metastases of colorectal cancer. Int J Colorectal Dis. 2013;28:537–45.

    Article  PubMed  Google Scholar 

  20. Neeff H, Hörth W, Makowiec F, Fischer E, Imdahl A, Hopt UT, et al. Outcome after resection of hepatic and pulmonary metastases of colorectal cancer. J Gastrointest Surg. 2009;13:1813–20.

    Article  PubMed  Google Scholar 

  21. Headrick JR, Miller DL, Nagorney DM, Allen MS, Deschamps C, Trastek VF, et al. Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg. 2001;71:975–9.

    Article  PubMed  CAS  Google Scholar 

  22. Brouquet A, Vauthey JN, Contreras CM, Walsh GL, Vaporciyan AA, Swisher SG, et al. Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease. J Am Coll Surg. 2011;213:62–9.

    Article  PubMed  Google Scholar 

  23. Gonzalez M, Robert JH, Halkic N, Mentha G, Roth A, Perneger T, et al. Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases. World J Surg. 2012;36:386–91.

    Article  PubMed  Google Scholar 

  24. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8–10.

    PubMed  CAS  Google Scholar 

  25. Folkman T. Tumor angiogenesis. Adv Cancer Res. 1985;43:175–203.

    Article  PubMed  CAS  Google Scholar 

  26. Kamiyoshihara M, Hirai T, Kawashima O, Morishita Y. Resection of pulmonary metastases in six patients with disease-free interval greater than 10 years. Ann Thorac Surg. 1998;66:231–3.

    Article  PubMed  CAS  Google Scholar 

  27. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335–42.

    Article  PubMed  CAS  Google Scholar 

  28. Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol. 2008;26:2013–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Mie Makiguchi, nurse in the General Thoracic Surgery Outpatient Department; Misato Ichida, scientific secretary of General Thoracic Surgery; General Thoracic Surgery nursing staffs; and all staff members involved in this research protocol.

Conflict of interest

The authors declare that we have received no financial support and have no relationships that may pose a conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mitsuhiro Kamiyoshihara.

Additional information

This article is based on the Japanese paper: “Kamiyoshihara M, et al. Lung metastasectomy for postoperative colorectal cancer in patients with a history of hepatic metastasis. Kyobu Geka. 2013;66: 291–7. Japanese.”

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kamiyoshihara, M., Igai, H., Kawatani, N. et al. Lung metastasectomy for postoperative colorectal cancer in patients with a history of hepatic metastasis. Gen Thorac Cardiovasc Surg 62, 314–320 (2014). https://doi.org/10.1007/s11748-014-0376-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-014-0376-z

Keywords

Navigation